Latest AI and machine learning research in other cancers for healthcare professionals.
Therapy-induced senescence (TIS) in cancer cells can be triggered by radiotherapy, chemotherapy, and certain targeted therapeutics. Here, we demonstrate that a new form of TIS, termed fatty acid synthesis therapy-induced senescence (FASTIS), can be induced by pharmacologically targeting de novo lipogenesis. Cancer cells can evade the anti-proliferative effects of clinically relevant inhibitors of ...
BACKGROUND: To develop and validate a multimodal MRI radiomics machine learning model for differentiating borderline epithelial ovarian tumors (BEOTs) from malignant epithelial ovarian tumors (MEOTs). METHODS: A total of 147 patients (72 with BEOTs and 75 with MEOTs) were retrospectively enrolled and randomly divided into training and test cohorts at a ratio of 7:3. Multivariate logistic regressio...
OBJECTIVES: To construct and validate a model based on clinical characteristics and magnetic resonance imaging (MRI) radiomics to predict 1-year effic...
OBJECTIVES: To develop a nomogram model for individualized prediction of neoadjuvant chemotherapy (NAC) response in locally advanced laryngeal cancer ...
Aging-related molecular reprogramming profoundly influences melanoma progression and therapeutic sensitivity, yet underlying mechanisms remain poorly ...
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy in which liver metastasis represents the principal determinant of po...
Research on novel treatment approaches is crucial for lung cancer, because it is one of the most common and aggressive malignancies with high mortalit...
BACKGROUND: As the histopathology workforce continues to struggle and service demand continues to increase, it has become prudent to consider viable a...
The tumor microenvironment (TME) critically shapes disease progression and therapeutic resistance. However, a comprehensive understanding of its spati...
Surgical resection is the standard treatment for nonmetastatic renal cell carcinoma, yet survival outcomes vary significantly among patients. Current ...
Despite advances in the management of head and neck squamous cell carcinoma (HNSCC), mortality within 6 months of diagnosis remains a substantial clin...
BACKGROUND: Nasopharyngeal carcinoma requires reliable diagnostic biomarkers due to its occult location and poor outcomes. METHODS: This study analyze...
Increasing evidence has highlighted the biological significance of 5-methylcytosine (5mC) DNA modification in regulating tumorigenesis and cancer prog...
Achieving complete resection of breast cancer with clear margins remains a significant surgical challenge, particularly for infiltrating subtypes, whe...
Conventional immune checkpoint inhibitors (ICIs) remain largely ineffective in microsatellite-stable metastatic colorectal cancer (MSS mCRC), where lo...
Antiepileptic drugs (AEDs) were frequently employed in glioma patients, especially those with low-grade glioma (LGG), in which epilepsy manifested in ...
Serum metabolic analysis based on label-free SERS fingerprints represents a highly promising technique for the detection of tumors. However, the insuf...
Acute myeloid leukemia (AML) remains a molecularly heterogeneous malignancy with poor prognosis, necessitating robust biomarkers for risk stratificati...
This study aimed to identify essential genes driving lung adenocarcinoma (LUAD) progression by integrating CRISPR-Cas9 dependency data from the Cancer...